R Squared’s Cardinal Health CAH Stock Holding History

R Squared’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-870	Closed	-$103K	–	495
2024 Q4	$103K	Buy	+870	New	+$102K	0.1%	250

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

R Squared's CAH Position: Q1 2025 in Review

R Squared sold out of Cardinal Health (CAH) in Q1 2025, closing a stake of 870 shares — an estimated $103K sold.

R Squared first reported a position in CAH in Q4 2024 and held it in 1 quarter. The position peaked at $103K in Q4 2024. 1,148 funds tracked by Wall St. Rank hold CAH as of Q1 2025.

R Squared reported no remaining Cardinal Health position as of Q1 2025 after selling out during the quarter.
R Squared sold 870 Cardinal Health shares in Q1 2025, an estimated $103K.
R Squared first reported a position in Cardinal Health in Q4 2024 and held it in 1 quarter.
R Squared's Cardinal Health position peaked at $103K in Q4 2024.
1,148 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.